BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

NCT06304922 · clinicaltrials.gov ↗

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer

Interventions

BEHAVIORAL: Assess the response to platinum-based chemotherapy in correlation to BRCA status in neoadjuvant and recurrent ovarian cancer

Sponsor

Assiut University